Connection

WAFIK ZAKY to Glioma

This is a "connection" page, showing publications WAFIK ZAKY has written about Glioma.
Connection Strength

1.411
  1. Diffuse intrinsic pontine glioma: time for therapeutic optimism. CNS Oncol. 2014; 3(5):337-48.
    View in: PubMed
    Score: 0.208
  2. Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab. Pediatr Hematol Oncol. 2013 Oct; 30(7):623-32.
    View in: PubMed
    Score: 0.204
  3. Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro Oncol. 2024 May 03; 26(Supplement_2):S155-S164.
    View in: PubMed
    Score: 0.106
  4. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
    View in: PubMed
    Score: 0.100
  5. Retrospective Analysis of Imaging Characteristics of Tectal Gliomas. J Comput Assist Tomogr. 2023 Jan-Feb 01; 47(1):136-143.
    View in: PubMed
    Score: 0.097
  6. Pediatric Central Nervous System Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 12; 20(12):1339-1362.
    View in: PubMed
    Score: 0.096
  7. Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J Clin Neurosci. 2021 Jul; 89:405-411.
    View in: PubMed
    Score: 0.087
  8. Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst. 2021 05; 37(5):1563-1572.
    View in: PubMed
    Score: 0.084
  9. Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma. Neuro Oncol. 2020 09 29; 22(9):1302-1314.
    View in: PubMed
    Score: 0.083
  10. Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities. J Neurooncol. 2020 Oct; 150(1):17-26.
    View in: PubMed
    Score: 0.081
  11. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019 Oct; 145(1):97-105.
    View in: PubMed
    Score: 0.077
  12. The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities. Cancer Metastasis Rev. 2017 12; 36(4):617-633.
    View in: PubMed
    Score: 0.068
  13. Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63.
    View in: PubMed
    Score: 0.068
  14. Preliminary experience with diffusion tensor imaging before and after re-irradiation treatments in children with progressive diffuse pontine glioma. Childs Nerv Syst. 2014 May; 30(5):925-30.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.